Jenny H. Chang

Targeting renal cell carcinoma with a HIF-2 antagonist

Wenfang Chen, Haley Hill, Alana Christie et al. · Nature · 2016 · 697 citations · Full text

Urology, Genitourinary Cancer, Renal Cell Carcinoma +4

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

Andreas Makris, T.J. Powles, S. Ashley et al. · Annals of Oncology · 1998 · 317 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +9

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma

Kevin D. Courtney, Yuanqing Ma, Alberto Diaz de Leon et al. · Clinical Cancer Research · 2019 · 177 citations · Full text

Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy

L. Assersohn, T.J. Powles, S. Ashley et al. · Annals of Oncology · 1999 · 58 citations

Surgical Oncology, Local Relapse, Breast Oncology +9

Listeriosis in Bone Marrow Transplant Recipients: Incidence, Clinical Features, and Treatment

Jenny H. Chang, R Powles, Jayesh Mehta et al. · Clinical Infectious Diseases · 1995 · 50 citations